Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

NCT03559413 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults

Interventions

BIOLOGICAL: Individual peptide vaccination with adjuvant GM-CSF and Imiquimod

Sponsor

University Children's Hospital Tuebingen

Collaborators

[object Object]
[object Object]
[object Object]